6 TECH OUTLOOKNovember 2017Copyright © 2017 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 1 - 2017Mailing AddressValleyMedia Inc.44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510 230 0396, F:510-894-8405 NOVEMBER - 1 - 2017, Vol 03 - 07 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithEditorial StaffSalesVisualizerAsher BlakeSudhin ThomasAaron Pierce Alex D'SouzaAva GarciaJenna VegasJoshua ParkerKarthik RamakrishnanDRUG DISCOVERY AND DEVELOPMENT SPECIALEdwin Josephedwin@pharmatechoutlook.comT: 510-493-7546EditorialStacey Smith Editor-in-ChiefThe pharmaceutical sector today is taking giant leaps into the future by striving to find new ways to store and manage data, put a price on medical treatments and handle endowed patients. In a market sector as competitive as this, the burden of deciding which technology to adopt for prominent pharma processes lies heavy on the shoulders of the CIOs and life science decision makers. After all, the need for discovering and developing newer drugs into the market is ever-growing. Researchers discover new drugs through means of various innovative methods, providing fresh ways to target medical products to specific sites within the body. Pharmaceutical companies need to ensure that the medications released to the public are not only safe but effectual.The process of recognizing and developing new drugs into the market is an extremely costly and time-consuming effort. On an average, it takes close to ten years for a new medicine to complete the journey from initial discovery to getting released into the marketplace, wherein the clinical trials alone take six to seven years. The average cost to research and develop each successful drug is estimated to be about $2.6 billion. In fact, the likelihood that a drug entering clinical testing will eventually get approved is only 12 percent. The overall process is thus tedious, with each drug undergoing a stringent process of uncovering, development and approval. Developing successful drugs requires immense resources working collaboratively: the best scientific minds, highly sophisticated technologies, ever-evolving manufacturing processes and complex project management. This is where Pharma Tech Outlook wishes to make an impact. This edition wishes to bring forth real-world solutions and product trends to this competitive landscape by adapting an eye-opening peer-to-peer approach. We bring to you the Top 10 Drug Discovery and Development solutions in the market today, that include insight from some of the more experienced experts in the industry, while presenting sufficient proficiency in the technology arena.Let us know your thoughts.The Metamorphosis of Pharmaceutical ManufacturingTECH OUTLOOKTECH OUTLOOK*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staff
< Page 5 | Page 7 >